Scribd Logo
Upload

Welcome to Scribd!

  • 15 views

    Divi's Laboratories - ACF GRP 2 - Rohan Guwalani - JN23PGC048

    Uploaded by

    gaurav.jain.25n

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd

    Divi's Laboratories - ACF GRP 2 - Rohan Guwalani - JN23PGC048

    Uploaded by

    gaurav.jain.25n
    15 views9 pages

    Original Title

    Divi's Laboratories _ ACF Grp 2 _ Rohan Guwalani _ JN23PGC048

    Copyright

    © © All Rights Reserved

    Available Formats

    XLSX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd
    Download as xlsx, pdf, or txt
    15 views9 pages

    Divi's Laboratories - ACF GRP 2 - Rohan Guwalani - JN23PGC048

    Uploaded by

    gaurav.jain.25n

    Copyright:

    © All Rights Reserved
    Download as XLSX, PDF, TXT or read online from Scribd
    Download as xlsx, pdf, or txt
    of 9

    Allotted Company Recast Financial Statements (All Values in Crores, Except for Per Share Data)

    INCOME STATEMENTS BALANCE SHEETS


    2022 2023 Assets 2022 2023
    Net sales 8879.82 7625.30 Cash 2803.68 2108.47
    COGS (excl. depr.) 2989.80 3029.65 ST Investments
    Gross Profit 5890.02 4595.65 Accounts receivable 2,570 1,964
    Depreciation 310.55 342.07 Others 278 2,382
    Other operating expenses 2247.97 2013.56 Inventories 2,644 2,780
    EBIT 3331.50 2240.02 Total CA 8295.96 9235.45
    Interest expense 0.65 0.52 Net NCA 5011.90 5116.17
    Profit Before Tax 3330.85 2239.50 Total assets 13307.86 14351.62
    Taxes 727.98 545.95
    Profit after Tax 2602.87 1693.55
    Non-recurring items 2.18 2.33 Liabilities and Equity
    Net income 2605.05 1695.88 Accounts payable 771.30 742.64
    Financial liab 62.89 43.39
    Other Data others 334.21 292.34
    Equity dividends 58.00 74.00 Total CL 1168.40 1078.37
    Addition to other equity 2547.05 1621.88 Long-term debt 448.11 567.83
    Tax rate 30% 30% Total liabilities 1616.51 1646.20
    Equity shares (no.) 50 50
    CMP per share 132.00 155.00 Equity share capital 53 53
    Other equity 11,638 12,652
    Shareholders funds 11691.35 12705.42
    Total liabs. & equity 13307.86 14351.62
    S.No. Name CMP P/E Sales Assets
    1 Jubilant Pharmo 562.45 244.8 6622.3 11399.6
    2 Neuland Labs. 5916.85 24.02 1580.64 1665.06
    3 Aarti Drugs 452.6 26.23 2403.79 2114.36
    4 Ami Organics 1067.65 55.24 678.9 968.01
    5 Hikal 278 47.78 1815.79 2390.85
    6 Guj. Themis Bio. 369.3 48.82 156.27 197.38
    7 SMS Pharma. 188.6 38.41 612.89 1011.89
    8 NGL Fine Chem 2065.1 35.25 307.53 321.85
    9 Beta Drugs Ltd 1208.5 33.43 255.99 237.27
    10 Anuh Pharma 227.6 20.99 640.42 399.73

    FUV Divi's Lab. - - 7493 14283

    Equity Multiples
    S.No. Peers Sales PAT CF BV
    Jubilant Pharmo 636 21253 791
    Neuland Labs. 28049 25809 68118 3200
    Aarti Drugs 1411 3939 28330 1782
    Ami Organics 11784 20700 2982
    Hikal 1147 5367 41652 1429
    Guj. Themis Bio. 17708 9293 46436 7198
    SMS Pharma. 2306 6275 1485
    NGL Fine Chem 50316 78874 1290181 2507
    Beta Drugs Ltd 35374 48097 464401 3908
    Anuh Pharma 2663 5796 8628 2122
    Divi's Lab. 15139 22540 278249 2740
    Super avg 69211
    Free Cash FlowPAT EBIT EV / EBITDA B.V. Rs. EV
    -135.14 36.6 392.7 12.33 339.62 11653.64
    172.57 317.06 434.06 15.4 882.92 7555.61
    31.74 158.91 242.58 16.09 121.31 4658.34
    -30.87 71.33 117.57 29.77 170.96 3934.44
    13.26 71.63 150.85 15.84 92.88 4165.13
    15.8 54.96 74.1 34.59 24.5 2680.42
    -7.21 41.57 79.11 16.63 60.66 1840.29
    3.18 36.21 48.74 22.67 393.4 1286.63
    5.17 34.75 49.11 19.19 147.67 1153.91
    52.41 54.31 71.7 14.1 51.23 1134.31

    1986.72 1383 1917 38.85 477.53 88850.05

    es Enterprise Value Multiples


    ASSETS EBIT EBITDA BV
    705 2746 1361 791
    50755 26131 27581 3200
    3057 3577 3575 1782
    15753 17408 18475 2982
    1661 3533 2418 1429
    26724 9554 10899 7198
    2662 4570 3898 1485
    91645 81223 83216 2507
    72748 47174 45964 3908
    8133 6085 6470 2122
    27384 20200 20386 2740
    14442
    Mar Cap EBITDA
    8959.84 945
    7591.2 491
    4160.98 290
    3937.59 132
    3427.77 263
    2682.79 77.5
    1596.52 111
    1276.23 56.8
    1161.83 60.1
    1140.6 80.4

    92456.05 2287

    You might also like